2love

2love Middle East latest: Israeli raid and airstrikes in West Bank kill at least 8 Palestinians

Sportscaster Greg Gumbel dies from cancer at age 78Pam Bondi, Donald Trump's pick to be attorney general, is a staunch ally of the former president, defending him against impeachment during his first term and pushing his false claims of election fraud as he sought to cling on to the White House. The 59-year-old former Florida attorney general, if confirmed by the Senate, will now serve as the top law enforcement official in a second Trump administration. "For too long, the partisan Department of Justice has been weaponized against me and other Republicans -- Not anymore," Trump wrote on his Truth Social network. "Pam will refocus the DOJ to its intended purpose of fighting Crime, and Making America Safe Again." Bondi's nomination means the top ranks of the Justice Department will be filled by Trump loyalists, as the president-elect has named three of the lawyers who defended him in his multiple criminal cases to its other high-ranking roles. Trump tapped Bondi to be attorney general on Thursday after his first pick, firebrand ex-Florida lawmaker Matt Gaetz, dropped out amid sexual misconduct allegations and doubts that he could obtain Senate confirmation. A graduate of the University of Florida with a law degree from Stetson University, Bondi served as a prosecutor for 18 years before being elected attorney general of the "Sunshine State" in 2010, the first woman to hold the post. Bondi, a native of Trump's adopted home state of Florida, was reelected to a second term in 2014. As attorney general, Bondi notably fought opioid addiction and human trafficking while taking a tough stance on crime and supporting the death penalty. She sued BP for the 2010 Deepwater Horizon oil spill in the Gulf of Mexico and obtained more than $2 billion in economic relief for Florida, according to her biography page at Ballard Partners, a powerful lobbying firm where she has worked after leaving office. While serving as attorney general, Bondi was drawn into a controversy involving Trump when she declined in 2013 to join a multi-state prosecution accusing Trump University of fraud. It emerged later that Bondi's reelection committee had received a $25,000 donation from the charitable Trump Foundation. Both Trump and Bondi denied any wrongdoing. Bondi joined Trump's legal team during his first impeachment trial, in which he was alleged to have pressured Ukrainian President Volodymyr Zelensky to find political dirt on his 2020 election opponent, Democrat Joe Biden. Trump was impeached by the Democrat-controlled House of Representatives but acquitted by the Republican-majority Senate. After the 2020 election, Bondi made television appearances on behalf of Trump and pushed to de-legitimize vote counting in battleground states as part of the push by the former president to overturn the results of the vote. Bondi has also criticized the criminal cases brought against Trump, appearing in solidarity at his New York trial, where he was convicted of falsifying business records to cover up hush money payments to a porn star. At Ballard Partners, Bondi has done work for Amazon, General Motors and Uber and as a registered lobbyist for the oil-rich Gulf nation of Qatar, according to press reports. She is also a member of the America First Policy Institute, a Trump-aligned right-wing think tank. cl/dwXbox Fans Can Get Free Xbox Series X Console (But It’s Not Easy)

Light & Wonder, Inc. Announcement: If You Have Suffered Losses in Light & Wonder, Inc. ...By Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.Matt Gaetz says he won't return to Congress next year

Adventures on special teams made the Washington-Dallas showdown a clumsy affair, yet Joe Davis and Greg Olsen saw to it that the broadcast of the chaotic finish was pure gold. After Terry McLaurin weaved his way past five defenders for an 86-yard touchdown catch from Jayden Daniels to cut the Cowboys lead to 27-26 with 21 seconds left, Fox's No. 2 broadcast crew captured the chaos before admonishing the audience not to count on anything as a certainty on this helter-skelter afternoon. "Lightning strikes twice in Washington!" Davis shouted in an homage to Daniels' 52-yard Hail Mary to Noah Brown that stunned the Bears last month. "They dropped 11 guys in coverage," Olsen marveled. "If they just tackle him inbounds the game is over. I don't even know what to say. I'm absolutely speechless." Not for long he wasn't. People are also reading... Olsen quickly cautioned the audience that "Automatic" Austin Siebert had already missed an extra point along with a field goal Sunday in his return from a right hip injury. "Before anyone in Washington gets too fired up, remember, we've seen a missed PAT already," Olsen said. "Yeah, you hold your breath with anything special teams-related on this day," Davis agreed. After all, this was the first game in NFL history to feature two kickoff returns for touchdowns, two errant extra points and a blocked punt. In the 41-point fourth quarter that erased the game's snoozer status, Washington allowed KaVontae Turpin's 99-yard kickoff return for a score. Earlier, the Cowboys missed a field goal and saw another one blocked along with a punt. Sure enough, the snap was low ... the hold was better ... "It is no good!" Davis hollered. "And the worst special teams day in history has a fitting finish!" Actually, no. More ruckus remained. Siebert's onside kick bounced twice in front of safety Juanyeh Thomas, who gathered it in and returned it 43 yards for Dallas' second kickoff return for a touchdown. If Thomas takes a knee short of the goal line, he effectively seals the Cowboys' win. Instead, the score, while pushing Dallas' lead to 34-26, also left enough time for Daniels and the Commanders for a shot at yet another miracle touchdown. Austin Ekeler returned the kickoff to the Washington 36 and after a short gain, Daniels' Hail Mary was intercepted by Israel Mukuamu as time expired. And that's how what Davis called the "worst special teams day in NFL history" came to an end. "What a wild special teams moment of blocked punts, kicks, kickoff returns, blocked field goals," Commanders coach Dan Quinn said. In keeping with the not-so-special-teams theme, there were several foibles in the kicking game across the NFL in Week 12, where the Broncos gave up a 34-yard pass completion on a fake punt that Denver coach Sean Payton swore the team saw coming — and not as it was unfolding, either, but five days earlier. "We met Tuesday as a staff. It wasn't a matter of if, it was when they were going to run a fake punt," Payton said. "You're struggling as a team like this, we had it on the keys to victory, so credit them, they executed it." Thanks to AJ Cole's 34-yard pass to linebacker Divine Deablo that set up a second-quarter field goal, the reeling Raiders took a 13-9 advantage into the locker room, just their second halftime lead of the season. In the second half, the Raiders succumbed to surging rookie QB Bo Nix and veteran wide receiver Courtland Sutton in their 29-19 loss. That's seven straight losses for the Raiders, their longest skid in a decade. The Broncos (7-5), who blew a chance to beat the Chiefs in Week 10 when their 35-yard field goal try was blocked as time ran out, also allowed a 59-yard kickoff return that led to Las Vegas' only touchdown Sunday. The Texans (7-5) lost for the third time in four games after Ka'imi Fairbairn shanked a 28-yard field goal try that would have tied the Titans just after the two-minute warning. Like the Broncos, the Vikings (9-2) overcame a special teams blunder and escaped Soldier Field with a 30-27 overtime win against the Bears after allowing Chicago (4-7) to recover an onside kick with 21 seconds left. Caleb Williams followed with a 27-yard pass to D.J. Moore to set up Cairo Santos' tying 48-yard field goal as the fourth-quarter clock hit zeros. Be the first to know Get local news delivered to your inbox!By Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.Ed Bernstein Injury Lawyers And KTNV Celebrate Successful Renovations At St. Jude's Ranch For Children

FORT LAUDERDALE, Fla., Dec. 19, 2024 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) , an environmental services company specializing in methane abatement operations, took numerous steps in 2024 to accelerate the Company’s profitability and commercial momentum. Specifically, Zefiro’s success over the past twelve months can be attributed to its execution of the Company’s strategy to expand its commercial footprint in critical marketplaces across North America and generate industry-leading, American Carbon Registry-approved carbon credits via an expanding, nationwide orphaned oil and gas well plugging operation. By actively advancing numerous strategic initiatives and bolstering its internal infrastructure throughout 2024, Zefiro is poised to remain at the forefront of the environmental services industry and reach yet another slate of notable accomplishments in the year ahead. The Company’s 2024 highlights include: Recording consolidated revenues of USD $32.8 million and a positive adjusted EBITDA (that was doubled over the previous quarter) on the Company’s 2024 year-end earnings report; Facilitating an Initial Public Offering (IPO) on the Cboe Canada, Inc. stock exchange, with a subsequent listing on the Frankfurt Stock Exchange . Zefiro's common shares are also now quoted on the OTCQB in the U.S. under the symbol ZEFIF; Expanding the Company’s well plugging operations across the nation, including projects in West Virginia , Pennsylvania , Oklahoma , and Ohio ; Entering into a landmark methane abatement offset market-setting presale agreement with EDF Trading , adding to Zefiro's pipeline of carbon offset pre-sales with the first delivery of offset products set to take place in the new year; Finalizing a number of strategic acquisitions and corporate partnerships, including the whole-sale acquisition of Plants & Goodwin , a Pennsylvania-based oil and gas well plugging operation; Bolstering the Company’s senior leadership team by appointing longtime Wells Fargo executive Mohit Gupta as the Chief Financial Officer and Bain & Company alumnus Richard Walker to serve as Chief Technology Officer; and Featuring at numerous leading industry conferences and events, including UN COP29 , NYC Climate Week , Wall Street Green Summit , Argus Europe Climate Conference , and more. Crew members contracted by Zefiro subsidiary Plants & Goodwin on-site at an Ohio-based well plugging operation in November 2024. Readers using news aggregation services may be unable to view the link provided above. Please access SEDAR+ or the Investors section of the Company’s website for a version of this press release containing links and media. Zefiro Founder and Chief Executive Officer Talal Debs commented, “From our plugging crews completing projects across the country to our expert team of carbon market specialists connecting with customers throughout the world, we have strived to invest in the resources needed to position each of our dedicated team members for success. The string of new milestones that we have been able to achieve over the past twelve months is directly linked to our senior management team’s commitment to that process, and I am incredibly proud that the progress that our team has earned in 2024 will guide our positive commercial momentum well into the future.” Zefiro Chief Financial Officer Mohit Gupta commented, “2024 has been a transformative year for Zefiro, and our ability to garner sustainable, increasing returns for our investors is a direct result of the unwavering dedication and expertise of our entire team. Through consistent execution of our comprehensive, client service-oriented strategy, we have established our position as a market leader, forged a consistent pipeline of project opportunities, and helped more communities safeguard public health.” About Zefiro Methane Corp. Zefiro is an environmental services company, specializing in methane abatement. Zefiro strives to be a key commercial force towards Active Sustainability. Leveraging decades of operational expertise, Zefiro is building a new toolkit to clean up air, land, and water sources directly impacted by methane leaks. The Company has built a fully integrated ground operation driven by an innovative monetization solution for the emerging methane abatement marketplace. As an originator of high-quality U.S.-based methane offsets, Zefiro aims to generate long-term economic, environmental, and social returns. On behalf of the Board of Directors of the Company, ZEFIRO METHANE CORP. “Talal Debs” Talal Debs, Founder & CEO For further information, please contact: Zefiro Investor Relations 1 (800) 274-ZEFI (274-9334) investor@zefiromethane.com For media inquiries, please contact: Rich Myers - Profile Advisors (New York) media@zefiromethane.com +1 (347) 774-1125 Forward-Looking Statements This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information is often, but not always, identified by the use of words such as “seeks”, “believes”, “plans”, “expects”, “intends”, “estimates”, “anticipates” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. In particular, this news release contains forward-looking information including statements regarding: the Company’s intention to reduce emissions from end-of-life oil and gas wells and eliminate methane gas; the Company’s partnerships with industry operators, state agencies, and federal governments; the Company’s expectations for continued increases in revenues and EBITDA growth as a result of these partnerships; the Company’s intentions to build out its presence in the United States; the anticipated federal funding for orphaned well site plugging, remediation and restoring activities; the Company’s expectations to become a growing environmental services company; the Company’s ability to provide institutional and retail investors alike with the opportunity to join the Active Sustainability movement; the Company’s ability to generate long-term economic, environmental, and social returns; and other statements regarding the Company’s business and the industry in which the Company operates. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include, but are not limited to: (i) adverse general market and economic conditions; (ii) changes to and price and volume volatility in the carbon market; (iii) changes to the regulatory landscape and global policies applicable to the Company's business; (iv) failure to obtain all necessary regulatory approvals; and (v) other risk factors set forth in its Prospectus dated April 8, 2024 under the heading “Risk Factors”. The Company operates in a rapidly evolving environment where technologies are in the early stage of adoption. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. Forward-looking information in this news release is based on the opinions and assumptions of management considered reasonable as of the date hereof, including, but not limited to, the assumption that general business and economic conditions will not change in a materially adverse manner. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information. The forward-looking information included in this news release is made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. Statement Regarding Third-Party Investor Relations Firms Disclosures relating to investor relations firms retained by Zefiro Methane Corp. can be found under the Company's profile on SEDAR+ at www.sedarplus.ca/ . A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6a438934-f40c-440b-b8a7-af17ae78c414Knicks News: Matt Ryan Agrees to 2-Way Contract; Boo Buie Waived

Michigan upsets No. 2 Ohio State 13-10 for Wolverines' 4th straight win over bitter rival

Mahayuti swearing-in on Dec 5, all eyes on Eknath Shinde’s next move

By MICHELLE L. PRICE WEST PALM BEACH, Fla. (AP) — An online spat between factions of Donald Trump’s supporters over immigration and the tech industry has thrown internal divisions in his political movement into public display, previewing the fissures and contradictory views his coalition could bring to the White House. The rift laid bare the tensions between the newest flank of Trump’s movement — wealthy members of the tech world including billionaire Elon Musk and fellow entrepreneur Vivek Ramaswamy and their call for more highly skilled workers in their industry — and people in Trump’s Make America Great Again base who championed his hardline immigration policies. The debate touched off this week when Laura Loomer , a right-wing provocateur with a history of racist and conspiratorial comments, criticized Trump’s selection of Sriram Krishnan as an adviser on artificial intelligence policy in his coming administration. Krishnan favors the ability to bring more skilled immigrants into the U.S. Loomer declared the stance to be “not America First policy” and said the tech executives who have aligned themselves with Trump were doing so to enrich themselves. Much of the debate played out on the social media network X, which Musk owns. Loomer’s comments sparked a back-and-forth with venture capitalist and former PayPal executive David Sacks , whom Trump has tapped to be the “White House A.I. & Crypto Czar.” Musk and Ramaswamy, whom Trump has tasked with finding ways to cut the federal government , weighed in, defending the tech industry’s need to bring in foreign workers. It bloomed into a larger debate with more figures from the hard-right weighing in about the need to hire U.S. workers, whether values in American culture can produce the best engineers, free speech on the internet, the newfound influence tech figures have in Trump’s world and what his political movement stands for. Trump has not yet weighed in on the rift, and his presidential transition team did not respond to a message seeking comment. Musk, the world’s richest man who has grown remarkably close to the president-elect , was a central figure in the debate, not only for his stature in Trump’s movement but his stance on the tech industry’s hiring of foreign workers. Technology companies say H-1B visas for skilled workers, used by software engineers and others in the tech industry, are critical for hard-to-fill positions. But critics have said they undercut U.S. citizens who could take those jobs. Some on the right have called for the program to be eliminated, not expanded. Born in South Africa, Musk was once on an a H-1B visa himself and defended the industry’s need to bring in foreign workers. “There is a permanent shortage of excellent engineering talent,” he said in a post. “It is the fundamental limiting factor in Silicon Valley.” Related Articles National Politics | Should the U.S. increase immigration levels for highly skilled workers? National Politics | Trump threat to immigrant health care tempered by economic hopes National Politics | In states that ban abortion, social safety net programs often fail families National Politics | Court rules Georgia lawmakers can subpoena Fani Willis for information related to her Trump case National Politics | New 2025 laws hit hot topics from AI in movies to rapid-fire guns Trump’s own positions over the years have reflected the divide in his movement. His tough immigration policies, including his pledge for a mass deportation, were central to his winning presidential campaign. He has focused on immigrants who come into the U.S. illegally but he has also sought curbs on legal immigration , including family-based visas. As a presidential candidate in 2016, Trump called the H-1B visa program “very bad” and “unfair” for U.S. workers. After he became president, Trump in 2017 issued a “Buy American and Hire American” executive order , which directed Cabinet members to suggest changes to ensure H-1B visas were awarded to the highest-paid or most-skilled applicants to protect American workers. Trump’s businesses, however, have hired foreign workers, including waiters and cooks at his Mar-a-Lago club , and his social media company behind his Truth Social app has used the the H-1B program for highly skilled workers. During his 2024 campaign for president, as he made immigration his signature issue, Trump said immigrants in the country illegally are “poisoning the blood of our country” and promised to carry out the largest deportation operation in U.S. history. But in a sharp departure from his usual alarmist message around immigration generally, Trump told a podcast this year that he wants to give automatic green cards to foreign students who graduate from U.S. colleges. “I think you should get automatically, as part of your diploma, a green card to be able to stay in this country,” he told the “All-In” podcast with people from the venture capital and technology world. Those comments came on the cusp of Trump’s budding alliance with tech industry figures, but he did not make the idea a regular part of his campaign message or detail any plans to pursue such changes.

Middle East latest: Israeli raid and airstrikes in West Bank kill at least 8 Palestinians

Opinions expressed by Digital Journal contributors are their own Large language models are 1D models, they understand text. Temporal computing is making Artificial intelligence (AI) to understand the concept of time. Artificial intelligence (AI) memory systems are changing how machines process information, enabling them to store, retrieve, and analyze data over time. Shawn Shen , assistant professor at the University of Bristol, focuses on developing practical applications that bridge AI memory with user needs. His research in AI memory contributes to the field while addressing implementation challenges. These developments suggest potential changes in how AI systems support human activities. A Trinity College, University of Cambridge graduate, Shawn Shen distinguished himself early on, securing top honors for his undergraduate and master’s work in Information and Computer Engineering. Under the mentorship of luminaries like Professors Per Ola, he pursued a Ph.D. that delved into temporal intelligence—a niche field focusing on how AI can process and interpret sequences of events over time. His experience includes positions as a Research Scientist at Meta’s Reality Labs and leadership at OpenInterX, where he studies memory-driven AI systems. “The question isn’t just how machines can learn,” he notes, “but how they can remember and adapt to support human activities.” AI memory utilizes two main approaches: non-parametric memory for external information storage and parametric memory for embedded learning. These systems draw from research on human memory processes to improve contextual understanding. “Memory allows AI to contextualize actions, making interactions more practical,” Shawn Shen explains. The applications range from healthcare support to educational tools. For example, memory-enabled AI could assist patients with cognitive challenges or provide personalized learning experiences. Shawn Shen founded OpenInterX, and they developed Mavi, the world’s first multi-modal AI with long contextual memory, delivers mass video understanding at a fraction of the cost of industry leaders like Gemini-1.5-Pro and GPT-4 with vision. Offering exceptional performance across benchmarks, Mavi excels in long-form video understanding with memory-augmentation technology that preserves deep context. Mavi serves researchers, businesses, and creators with unmatched scalability and usability. Meanwhile, Shawn Shen also developed LUCI, a wearable AI assistant combining temporal computing with memory capabilities. The project aims to create an adaptive AI assistant system that provides relevant support based on user patterns and needs. LUCI is more than just an AI; it functions as a personalized assistant that shares memory with its users, retaining and contextualizing interactions to deliver deeply customized experiences. Built with a privacy-first architecture, the platform processes data locally, ensuring robust security while providing tailored functionality. This innovation was recently honored with the CES 2025 Innovation Award, proving its significance on the AI landscape. Shawn Shen’s work has earned recognition, including the CES Innovation Award for LUCI. In healthcare applications, his work explores how AI memory systems can provide practical support for patients with cognitive needs, focusing on reliable assistance rather than simply automated reminders. “AI memory development prioritizes practical applications,” he emphasizes. “The goal is to create useful tools that complement human capabilities.” The development of AI memory systems raises important questions about privacy and data security. Shawn Shen’s research emphasizes local data processing and user control over information storage and usage. “User trust depends on transparent system operation,” he notes. “Effective technology must prioritize user privacy and control.” Shawn Shen’s current research includes improving AI processing efficiency, particularly in video analysis. His work focuses on making AI systems more practical and cost-effective. “The aim is to develop AI that effectively supports human activities,” he concludes. His ongoing research suggests continued progress in creating practical AI tools that enhance human capabilities while addressing real-world implementation challenges.